Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 21, 2017; 23(47): 8376-8386
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8376
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8376
Figure 3 Nomograms for the prediction of recurrence-free survival (A) and overall survival (B) in patients following gastric neuroendocrine neoplasm resection; the C-index was 0.
788 and 0.759 for RFS and OS, respectively. LNR: Lymph node ratio; TA-NLR: Tumor-associated neutrophil-to-lymphocyte ratio.
- Citation: Cao LL, Lu J, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, Chen QY, Lin M, Tu RH, Huang CM. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms. World J Gastroenterol 2017; 23(47): 8376-8386
- URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8376.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8376